This article is more than 7 month old.

Novartis buys Vedere Bio, whose founders helped blind mice see

Mini

Swiss drugmaker Novartis is buying Vedere Bio, hoping gene therapy technology that has helped blind mice to see will produce similar results in people with inherited conditions that cause them to lose their sight.

Novartis buys Vedere Bio, whose founders helped blind mice see

Market Movers

CompanyPriceChange%Loss
CompanyPriceChange%Loss
CompanyPriceChange%Gain
CompanyPriceChange%Gain

Currency

CompanyPriceChng%Chng
Dollar-Rupee74.1600-0.1100-0.15
Euro-Rupee88.43900.02700.03
Pound-Rupee103.0450-0.4470-0.43
Rupee-100 Yen0.6688-0.0003-0.04

Market Movers

CompanyPriceChange%Loss
CompanyPriceChange%Loss
CompanyPriceChange%Loss
CompanyPriceChange%Loss

Currency

CompanyPriceChng%Chng
Dollar-Rupee74.1600-0.1100-0.15
Euro-Rupee88.43900.02700.03
Pound-Rupee103.0450-0.4470-0.43
Rupee-100 Yen0.6688-0.0003-0.04